Citigroup Maintains Neutral on Haemonetics, Raises Price Target to $88

Citigroup analyst Joanne Wuensch maintains Haemonetics (NYSE:HAE) with a Neutral and raises the price target from $80 to $88.

Citigroup analyst Joanne Wuensch maintains Haemonetics (NYSE:HAE) with a Neutral and raises the price target from $80 to $88.

Total
0
Shares
Related Posts
Read More

Last Day Of Q1

Wall Street bonuses fell 26% last year. This was the biggest drop since 2008. Wall Street is estimated to be responsible for 16% of all economic activity in NYC. Wild nights out for ibankers slowing down?

ACNT